Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 1
2006 1
2007 1
2019 1
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
[Early palliative care in oncology].
Bouleuc C, Burnod A, Angellier E, Massiani MA, Robin ML, Copel L, Chvetzoff G, Frasie V, Fogliarini A, Vinant P. Bouleuc C, et al. Among authors: angellier e. Bull Cancer. 2019 Sep;106(9):796-804. doi: 10.1016/j.bulcan.2019.04.006. Epub 2019 Jun 4. Bull Cancer. 2019. PMID: 31174856 Review. French.
Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre.
Thery L, Vaflard P, Vuagnat P, Soulie O, Dolbeault S, Burnod A, Laouisset C, Marchal T, Massiani MA, Bozec L, Bidard FC, Cottu P, Angellier E, Bouleuc C. Thery L, et al. Among authors: angellier e. BMJ Support Palliat Care. 2021 Apr 29:bmjspcare-2021-002946. doi: 10.1136/bmjspcare-2021-002946. Online ahead of print. BMJ Support Palliat Care. 2021. PMID: 33927013 Free PMC article.
[Fatal acute encephalopathy due to 5-fluorouracil treatment].
Mémain N, Angellier JF, Obadia E, Angellier E, Chelha R, Couprie R. Mémain N, et al. Among authors: angellier e. Presse Med. 2005 Dec 3;34(21):1637-40. doi: 10.1016/s0755-4982(05)84240-x. Presse Med. 2005. PMID: 16327703 French.
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study.
Piedbois P, Serin D, Priou F, Laplaige P, Greget S, Angellier E, Teissier E, Berdah JF, Fabbro M, Valenza B, Herait P, Jehl V, Buyse M. Piedbois P, et al. Among authors: angellier e. Ann Oncol. 2007 Jan;18(1):52-57. doi: 10.1093/annonc/mdl355. Epub 2006 Oct 17. Ann Oncol. 2007. PMID: 17047001 Free article. Clinical Trial.
11 results